Muhammad Salim

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

Christine B. Ambrosone, Gary Zirpoli, Alan D. Hutson et al. · Journal of Clinical Oncology · 2019 · 234 citations · Full text

Medicine, Oncology, Pharmacology +14

Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival

Rikki Cannioto, Alan D. Hutson, Shruti Dighe et al. · JNCI Journal of the National Cancer Institute · 2020 · 187 citations · Full text

Medicine, Health Behavior, Oncology +12

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer

Steven E. Schild, James A. Bonner, Thomas G. Shanahan et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 168 citations

Medicine, Oncology, Radiation Oncology +6

Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252

Edith A. Perez, Vera J. Suman, Kendrith M. Rowland et al. · Clinical Breast Cancer · 2005 · 137 citations

Medicine, Oncology, Breast Oncology +16

Prognostic Value of Proliferation, Apoptosis, Defective DNA Mismatch Repair, and p53 Overexpression in Patients With Resected Dukes' B2 or C Colon Cancer

Megan M Garrity, Lawrence J. Burgart, Michelle R. Mahoney et al. · Journal of Clinical Oncology · 2004 · 126 citations · Full text

Medicine, Oncology, Pathology +17